Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Graves ophthalmopathy.

¹Department of Ophthalmology, Section of Oculoplastic and Orbital Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA. bradley.elizabeth@mayo.edu

Current Opinion in Ophthalmology

|October 6, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle.

American journal of physiology. Endocrinology and metabolism·2011

Same author

Effects of central administration of insulin or l-NMMA on rat skeletal muscle microvascular perfusion.

Diabetes, obesity & metabolism·2010

Same author

Local hindlimb antioxidant infusion does not affect muscle glucose uptake during in situ contractions in rat.

Journal of applied physiology (Bethesda, Md. : 1985)·2010

Same author

Radiation-induced meningiomas involving the orbit.

Ophthalmic plastic and reconstructive surgery·2001

Same author

Adrenocortical carcinoma metastatic to the orbit.

Ophthalmic plastic and reconstructive surgery·2001

Same author

Surgical correction of blepharoptosis in patients with myasthenia gravis.

Ophthalmic plastic and reconstructive surgery·2001

Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026

Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026

Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026

Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026

Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026

Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026

See all related articles

Graves ophthalmopathy (GO) research explores its autoimmune origins, epidemiology, and treatment. Studies investigate the thyroid stimulating hormone receptor, immunity, and surgical techniques for better patient outcomes.

Area of Science:

Ophthalmology
Endocrinology
Immunology

Background:

Graves ophthalmopathy (GO) is an autoimmune condition affecting the thyroid and orbit.
The pathogenesis involves the thyroid stimulating hormone receptor and immune system components.

Purpose of the Study:

Investigate the roles of the thyroid stimulating hormone receptor and immunity in GO.
Examine GO epidemiology in relation to other diseases.
Evaluate current and novel therapeutic strategies.

Main Methods:

Epidemiological analysis of GO.
Studies on cellular and humoral immunity in GO.
Prospective evaluation of medical and radiation therapies.
Refinement of orbital decompression surgical techniques.

Related Experiment Videos

Main Results:

Ongoing investigation into the specific mechanisms of GO pathogenesis.
Insights into the epidemiological links between GO and other autoimmune/ocular conditions.
Evaluation of the efficacy and safety of existing and emerging GO treatments.

Conclusions:

Continued research is crucial for understanding GO pathogenesis.
Improved diagnostic tools and therapies are being developed.
Surgical techniques are advancing to enhance patient outcomes in Graves ophthalmopathy.